Latest Cash Flow And Funding News

International Equities Corporation Ltd (ASX:IEQ) posted a modest profit for the June 2026 quarter, reversing prior losses amid a challenging economic backdrop that forced the company to exit its hotel and tourism activities.

Core Lithium has kicked off open pit mining at Grants and underground development at BP33, backed by strong cash reserves and strategic asset divestment plans.

Locate Technologies has agreed to settle its remaining Locate2u revenue royalty by issuing 10 million shares to PURE Asset Management at a significant premium to market price, simplifying funding and improving cash flow.

Galilee Energy is gearing up to drill its Zydeco-1 well in Louisiana this July, aiming to kickstart near-term cash flow from a low-cost, low-risk gas-condensate project. The company’s newly formed US advisory board supports a strategy to scale production through repeatable Gulf Coast asset acquisitions.

Larvotto Resources is set to acquire Hammer Metals in a $54 million all-scrip deal, expanding its Mt Isa copper portfolio to over 530,000 tonnes of copper equivalent and backed by a $15 million strategic placement from Glencore.

Pacgold has restarted drilling at its Vertigo deposit and begun irrigating 100,000 tonnes of re-crushed material at White Dam, aiming to accelerate production restart and resource growth.

FBR Limited secured its first overseas Mantis welding robot sale, launched the Firehawk refractory robot, and expanded its Wall as a Service footprint in Victoria, while navigating a cash balance under $700,000.

InteliCare has locked in its largest-ever $8.8 million contract with mecwacare to deploy its AI-driven platform across 22 aged care homes, while appointing Angus Cameron as CEO to spearhead growth.

Liontown Limited delivered its strongest financial quarter since production began, achieving a self-funded quarter with a $33 million cash boost and surpassing underground mining targets ahead of schedule, while maintaining FY2026 guidance amid robust lithium market conditions.

Argent BioPharma secured a 48% stake in CannPal Animal Therapeutics, shipped its largest CannEpil® order to Ireland worth A$783,000, and filed a US provisional patent for its NanoBodies platform, underpinning its neuro-immune strategy and commercial growth.

Audalia Resources has unveiled a maiden Ore Reserve for its Medcalf vanadium-titanium-iron project alongside an updated Pre-feasibility Study outlining two viable development options with strong economic returns. The company faces a tight cash position but is pursuing a $450,000 capital raise to sustain progress.

Noxopharm signed a strategic MoU with Tezcat Biosciences, published major Sofra RNA research, and appointed Dr Olivier Laczka as CEO, while reporting positive safety data from its HERACLES trial and improving cash flow.